These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 20209481)

  • 1. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian nonparametric estimation of EQ-5D utilities for United States using the existing United Kingdom data.
    Kharroubi SA
    Health Qual Life Outcomes; 2017 Oct; 15(1):195. PubMed ID: 28985757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuation of preference-based measures: can existing preference data be used to generate better estimates?
    Kharroubi SA
    Health Qual Life Outcomes; 2018 Jun; 16(1):116. PubMed ID: 29866108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valuations of EQ-5D health states: are the United States and United Kingdom different?
    Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
    Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of Hong Kong and United Kingdom SF-6D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; Brazier JE; McGhee S
    Value Health; 2014 Jun; 17(4):397-405. PubMed ID: 24969000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation and comparison of EQ-5D health states' utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom.
    Galante J; Augustovski F; Colantonio L; Bardach A; Caporale J; Marti SG; Kind P
    Value Health; 2011; 14(5 Suppl 1):S60-4. PubMed ID: 21839901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Italian population-based values of EQ-5D health states.
    Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
    Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Japan and U.K. SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method.
    Kharroubi SA
    Appl Health Econ Health Policy; 2015 Aug; 13(4):409-20. PubMed ID: 25896874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hispanic valuation of the EQ-5D health states: a social value set for Latin Americans.
    Zarate V; Kind P; Chuang LH
    Value Health; 2008 Dec; 11(7):1170-7. PubMed ID: 18489516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valuation of preference-based measures: can existing preference data be used to select a smaller sample of health states?
    Kharroubi SA; Rowen D
    Eur J Health Econ; 2019 Mar; 20(2):245-255. PubMed ID: 29980950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating an EQ-5D population value set: the case of Japan.
    Tsuchiya A; Ikeda S; Ikegami N; Nishimura S; Sakai I; Fukuda T; Hamashima C; Hisashige A; Tamura M
    Health Econ; 2002 Jun; 11(4):341-53. PubMed ID: 12007165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments.
    Kontodimopoulos N; Aletras VH; Paliouras D; Niakas D
    Value Health; 2009; 12(8):1151-7. PubMed ID: 19558372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling a preference-based index for EQ-5D using a non-parametric Bayesian method.
    Kharroubi SA; Daher CA
    Qual Life Res; 2018 Nov; 27(11):2841-2850. PubMed ID: 30008157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling HUI 2 health state preference data using a nonparametric Bayesian method.
    Kharroubi SA; McCabe C
    Med Decis Making; 2008; 28(6):875-87. PubMed ID: 18971313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating quality weights for EQ-5D (EuroQol-5 dimensions) health states with the time trade-off method in Taiwan.
    Lee HY; Hung MC; Hu FC; Chang YY; Hsieh CL; Wang JD
    J Formos Med Assoc; 2013 Nov; 112(11):699-706. PubMed ID: 24183199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling valuations for Eq-5d health states: an alternative model using differences in valuations.
    Dolan P; Roberts J
    Med Care; 2002 May; 40(5):442-6. PubMed ID: 11961478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.
    Karlsson JA; Nilsson JÅ; Neovius M; Kristensen LE; Gülfe A; Saxne T; Geborek P
    Ann Rheum Dis; 2011 Dec; 70(12):2163-6. PubMed ID: 21859684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.